Committee on Immunization Practices (ACIP). Advisors to the
Centers for Disease Control and Prevention (CDC). Advisory Committee
on Immunization Practices. Use of anthrax vaccine in the United
States. Morbidity and Mortality Weekly Report (MMWR) 2000; 49
(RR-15) (Dec 15): 1-20. www.cdc.gov/mmwr/PDF/rr/rr4915.pdf
Armed Forces Eoidemiolorrical Board (AFEB), 1994 to present.
Advisors to the Assistant Secretary of Defense for Health Affairs
and the Surgeons General of the Armed Forces. Recommendations:
2002, www.tricare.osd.mil/afeb/, www.anthrax.mil/resource/library/afeb.asp
Cochrane Collaboration. 1998, 2004. Demicheli V, Rivetti D,
Deeks JJ, Jefferson T, Pratt M. The effectiveness and safety
of vaccines against human anthrax: A systematic review. Vaccine
1998; 16 (May-Jun): 880-4. www.anthrax.mil/media/pdf/ErrandSafety.pdf.
Updated in 2004: www.cochrane.org/cochrane/revabstr/ab000975.htm
FDA Panel on Bacterial
Vaccines and Toxoids, 1978, 1985. Advisors to the Food and Drug
Administration. Food and Drug Administration. Biological products;
Bacterial vaccines and toxoids; lmpfementation of efficacy review.
Federal Register 1985; 50 (Dec 13): 51002-117. www.anthrax.mil/media/pdf/Fed-Reg.pdf
Inglesby TV, Henderson DA, Bartlett JG, et al. Anthrax as a
biological weapon: Medical and public health management. Journal
of the American Medical Association 1999; 281 (May 12): 1735-45.
Inglesby TV, O’Toote T, Henderson DA, et al. Anthrax
as a biological weapon, 2002: Updated recommendations for management.
Journal of the American Medical Association 2002; 287(May 1):
2236-52. jama.ama-assn.org/cgi/content/short/287/17/2236 Published
Joellenbeck LM, Zwanziger L, Durch JS, Strom BL, editors. The
Anthrax Vaccine: Is it Safe? Does it Work? Washington, DC: National
Academy Press, April 2002, xxi + 265 pages. www.nap.edu/catalog/10310.html.
Summary for General Public: www.iom.edu/Object.File/Master/4/149/0.pdf
Summary for Policy Makers: www.iom.edu/Object.File/Master/4/150/0.pdf
Lange JL, Lesikar SE, Brundage JF, Rubertone MV. Comprehensive
systematic surveillance for adverse effects of anthrax vaccine
adsorbed, US Armed Forces, 1998-2000. Vaccine 2003; 21: 1620-28.
Pittman PR, Coonan KM, Gibbs PH, Scott HM, Cannon TL, McKee.
KT Jr. Long-term health effects of repeated exposure to multiple
vaccines. vaccine 2004; 23: 525-36. www.vaccines.mil/documents/library/Longtermhealtheffects.pdf
Sever JL, Brenner AI, Gale AD, Lyle JM, Moulton LH, West DJ.
Safety of anthrax vaccine: A review by the Anthrax Vaccine Expert
Committee (AVEC) of adverse events reported to the Vaccine Adverse
Event Reporting System (VAERS). Pharmacoepidemiology & Drug
Safety 2002; 11 (Apr-May): 189-202.
Sever JL, Brenner AI, Gale AD, Lyle JM, Moulton LH, Ward BJ,
West DJ. Safety of anthrax vaccine: An expanded review and evaluation
of adverse events reported to the Vaccine Adverse Event Reporting
System (VAERS). Pharmacoepidemiology & Drug Safety 2004;
13 (Dec): 825-840. www.anthrax.mil/media/pdf/SeverArticle.pdf
Sulsky SI, Grabenstein JD, Delbos RG. Disability among U.S.
Army personnel vaccinated against anthrax. Journal of Occupational
& Environmental Medicine 2004; 46: 1065-1075. http://www.anthrax.mil/documents/library/Anthrax2004.pdf